FDA Considering Use of Atypical Anti Psychotics For Children
The FDA is considering the use to atypical anti-psychotics for children and young teens.
These medications are usually reserved for adults with mental disease as a last ditch effort, mainly due to the side effects of the medications. Zyprexa, one of the listed medications under consideration, causes weight gain that can lead very easily into diabetes, and in some cases death. It and the others all can lead to very frightening ailments and problems in the people they are prescribed.
I have some family members on a few of these medications, and although I’m speaking from personal experience, it’s hard when a family member is going through these problems.
There’s always a chance that even with medication and other treatments, they will never be ‘normal’.
However, it is still frightening at the thought of younger and younger children being prescribed these medications. While there are some, very limited cases where this can be a logical option, they are few and far in between.
You hear everyday about younger and younger children having problems classified as ADHD. Could it simply be something normal. While I’m not one to proclaim all ailments as not real, things seem to be getting a little overzealous with classifying everything as a mental illness.
What happened to kids just being kids? While again I’m sure some of the cases there could be something to the diagnosis, the testing for a child having ADHD have been placed in the hands of already overworked teachers.
Now, with this looming overhead who will be the diagnosticians in this case? How many children could potentially be taking these medications? With the side effects as severe as they are, hopefully these won’t be overused much like Ritilin has been.
Related posts
Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically to your feed reader.
Comments
No comments yet.
Leave a comment